Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
11	13	Search

2025	Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing Cancer Drug Resistance Émilie Audrey Larose, Xinying Hua, Silin Yu, Amritha Thulaseedharan Pillai, Zongbi Yi, Haijun Yu
2024	SLC35A2 expression is associated with HER2 expression in breast cancer Discover Oncology Yiran Wang, Xiaobo Peng, Meihong Wu, Bin Wang, Tianran Chen, Xianbao Zhan
2023	Investigation into the Role of Long-Non-Coding RNA MIAT in Leukemia Non-Coding RNA Alessia Ostini, Mirna Mourtada-Maarabouni
2023	Retyping of triple‐negative breast cancer based on clustering method Expert Systems Bo Liu, Xingrui Li, Huina Wang, Shuangtao Zhao, Jianqiang Li, Guangzhi Qu, Fei Wang
2023	Polymorphisms within DIO2 and GADD45A genes increase the risk of liver disease progression in chronic hepatitis b carriers Scientific Reports Magda Rybicka, Eloi R. Verrier, Thomas F. Baumert, Krzysztof Piotr Bielawski
2023	Risk prediction for dermatomyositis-associated hepatocellular carcinoma BMC Bioinformatics Xusheng Zhang, Yongxin Ma, Kejun Liu, Long Chen, Lin Ding, Weihu Ma, Bendong Chen
2020	Interplay between BRCA1 and GADD45A and Its Potential for Nucleotide Excision Repair in Breast Cancer Pathogenesis International Journal of Molecular Sciences Sylwia Pietrasik, Gabriela Zajac, Jan Morawiec, Miroslaw Soszynski, Michal Fila, Janusz Blasiak
2020	Development and validation of a novel epigenetic signature for predicting prognosis in colon cancer Journal of Cellular Physiology Dakui Luo, Qi Liu, Zezhi Shan, Sanjun Cai, Qingguo Li, Xinxiang Li
2020	Vitamin D in Triple-Negative and BRCA1-Deficient Breast Cancer—Implications for Pathogenesis and Therapy International Journal of Molecular Sciences Janusz Blasiak, Elzbieta Pawlowska, Jan Chojnacki, Joanna Szczepanska, Michal Fila, Cezary Chojnacki
	Additional cited-by details will be shown when available from Crossref